In 2018, Enorama Pharma obtained a wholesale license. Wholesale licenses are issued by the Swedish Medical Products Agency, which ensures that the company complies with the applicable Good Distribution Practice (GDP) rules. To get the license extended, the Swedish Medical Products Agency conducts regular inspections at the company. Enorama Pharma was inspected on December 18, 2019 with only a few minor deviations noted. On April 20, the Swedish Medical Products Agency announced the positive news that Enorama Pharma's wholesale license was approved and extended until December 2024.